These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 11376494

  • 1. Effect of Helicobacter pylori eradication on cyclooxygenase 2 (COX-2) and inducible nitric oxide synthase (iNOS) expression during gastric adaptation to aspirin (ASA) in humans.
    Fischer H, Huber V, Boknik P, Luess H, Neumann J, Schmitz W, Domschke W, Konturek JW.
    Microsc Res Tech; 2001 Jun 01; 53(5):336-42. PubMed ID: 11376494
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cyclooxygenase-2 expression in gastric antral mucosa before and after eradication of Helicobacter pylori infection.
    McCarthy CJ, Crofford LJ, Greenson J, Scheiman JM.
    Am J Gastroenterol; 1999 May 01; 94(5):1218-23. PubMed ID: 10235197
    [Abstract] [Full Text] [Related]

  • 4. Heat shock protein 70 (HSP70) in gastric adaptation to aspirin in Helicobacter pylori infection.
    Konturek JW, Fischer H, Konturek PC, Huber V, Boknik P, Luess H, Neumann J, Brzozowski T, Schmitz W, Hahn EG, Domschke W, Konturek SJ.
    J Physiol Pharmacol; 2001 Mar 01; 52(1):153-64. PubMed ID: 11321509
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Anti-inflammatory effect of two isoforms of COX in H. pylori-induced gastritis in mice: possible involvement of PGE2.
    Tanigawa T, Watanabe T, Hamaguchi M, Sasaki E, Tominaga K, Fujiwara Y, Oshitani N, Matsumoto T, Higuchi K, Arakawa T.
    Am J Physiol Gastrointest Liver Physiol; 2004 Jan 01; 286(1):G148-56. PubMed ID: 12958020
    [Abstract] [Full Text] [Related]

  • 7. Effect of vitamin C-releasing acetylsalicylic acid on gastric mucosal damage before and after Helicobacter pylori eradication therapy.
    Konturek PC, Kania J, Gessner U, Konturek SJ, Hahn EG, Konturek JW.
    Eur J Pharmacol; 2004 Dec 15; 506(2):169-77. PubMed ID: 15588738
    [Abstract] [Full Text] [Related]

  • 8. Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis.
    Fu S, Ramanujam KS, Wong A, Fantry GT, Drachenberg CB, James SP, Meltzer SJ, Wilson KT.
    Gastroenterology; 1999 Jun 15; 116(6):1319-29. PubMed ID: 10348815
    [Abstract] [Full Text] [Related]

  • 9. Effect of Helicobacter pylori eradication on anti-thrombotic dose aspirin-induced gastroduodenal mucosal injury.
    Giral A, Ozdogan O, Celikel CA, Tozun N, Ulusoy NB, Kalayci C.
    J Gastroenterol Hepatol; 2004 Jul 15; 19(7):773-7. PubMed ID: 15209624
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of the effects of Helicobacter pylori eradication therapy on gastric antral epithelial hyperproliferation: a prospective six-month follow-up study.
    Demiray M, Gulten M, Manavoglu O, Evrensel T, Ulukaya E, Yerci O, Kanat O, Kurt E, Arslan M, Gonullu G, Demiray H, Gulten T, Memik F.
    Hepatogastroenterology; 2004 Jul 15; 51(59):1531-5. PubMed ID: 15362794
    [Abstract] [Full Text] [Related]

  • 11. Short-term/low-dose aspirin-induced duodenal erosions are not dependent on Helicobacter pylori infection, cyclooxygenase expression and prostaglandin E2 levels.
    Venerito M, Treiber G, Wex T, Kuester D, Roessner A, Mönkemüller K, Malfertheiner P.
    Scand J Gastroenterol; 2008 Jul 15; 43(7):801-9. PubMed ID: 18584518
    [Abstract] [Full Text] [Related]

  • 12. Aspirin, but not NO-releasing aspirin (NCX-4016), interacts with selective COX-2 inhibitors to aggravate gastric damage and inflammation.
    Wallace JL, Zamuner SR, McKnight W, Dicay M, Mencarelli A, del Soldato P, Fiorucci S.
    Am J Physiol Gastrointest Liver Physiol; 2004 Jan 15; 286(1):G76-81. PubMed ID: 14665439
    [Abstract] [Full Text] [Related]

  • 13. Higher gastric cycloxygenase-2 expression and precancerous change in Helicobacter pylori-infected relatives of gastric cancer patients.
    Sheu BS, Yang HB, Sheu SM, Huang AH, Wu JJ.
    Clin Cancer Res; 2003 Nov 01; 9(14):5245-51. PubMed ID: 14614005
    [Abstract] [Full Text] [Related]

  • 14. Helicobacter pylori and gastric adaptation to repeated aspirin administration in humans.
    Konturek JW, Dembiński A, Konturek SJ, Domschke W.
    J Physiol Pharmacol; 1997 Sep 01; 48(3):383-91. PubMed ID: 9376621
    [Abstract] [Full Text] [Related]

  • 15. Cross-talk between inducible nitric oxide synthase and cyclooxygenase in Helicobacter-pylori-induced gastritis.
    Franco L, Talamini G.
    Med Princ Pract; 2009 Sep 01; 18(6):477-81. PubMed ID: 19797925
    [Abstract] [Full Text] [Related]

  • 16. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
    Ohara T, Kanoh Y, Higuchi K, Arakawa T, Morisita T.
    Hepatogastroenterology; 2003 Sep 01; 50(51):607-9. PubMed ID: 12828043
    [Abstract] [Full Text] [Related]

  • 17. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
    Güliter S, Keleş H, Ozkurt ZN, Cengiz DU, Kolukisa E.
    Turk J Gastroenterol; 2005 Mar 01; 16(1):29-33. PubMed ID: 16252185
    [Abstract] [Full Text] [Related]

  • 18. Role of cyclooxygenase (COX)-1 and COX-2 inhibition in nonsteroidal anti-inflammatory drug-induced intestinal damage in rats: relation to various pathogenic events.
    Tanaka A, Hase S, Miyazawa T, Ohno R, Takeuchi K.
    J Pharmacol Exp Ther; 2002 Dec 01; 303(3):1248-54. PubMed ID: 12438549
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
    Asaka M, Kato M, Sugiyama T, Satoh K, Kuwayama H, Fukuda Y, Fujioka T, Takemoto T, Kimura K, Shimoyama T, Shimizu K, Kobayashi S, Japan Helicobacter pylori Eradication Study Group.
    J Gastroenterol; 2003 Dec 01; 38(4):339-47. PubMed ID: 12743773
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.